• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Christopher Crow, M.D., MBA, of Catalyst Health Network on Patient Access and PCMHs, Clinically Integrated Networks, and Medicaid Expansion in Texas

Article

In this latest episode of the MHE Talks: Improving Patient Access series, Senior Editor Peter Wehrwein spoke with Dr. Christopher Crow, resident of Catalyst Health Network, a clinically integrated network of more than 1,000 primary care physicians throughout Texas. Peter and Dr. Crow discuss how his small-town roots and doctors there inspired his thinking about access issues; his experience with patient-centered medical homes and setting patient access as a priority; how Catalyst supports physicians in improving access; and the lack of Medicaid expansion in Texas and how that affects access there.

Christopher Crow

Christopher Crow

Related Content
© 2024 MJH Life Sciences

All rights reserved.